Table 1.
miRNA | Up-/Downregulated | Target | Possible Roles | Model | References | Cellular Process | |
---|---|---|---|---|---|---|---|
miR-23a | Down- then Upregulated | IRF1 | Inhibition of innate immune response and cell survival | HeLa | [66] | APOPTOSIS | |
miR-649 | Downregulated | MALT1 | Inhibition of innate and adaptive immune response | HeLa | [78] | ||
miR-101 | Upregulated | ATP5B | Blocking DNA packaging and capsid maturation | HeLa | [79] | INHIBITION OF VIRAL REPLICATION | |
Upregulated | GRSF1 | Inhibition of viral protein synthesis | HeLa | [80] | |||
miR-132 | Upregulated | Ras-GAP | Immuno-inflammatory response leading to neovascularization and stromal keratitis lesions | Murine corneas | [81] | ANTIVIRAL IMMUNITY | |
Upregulated | p300 | Inhibition of innate immune response | Monocytes (THP-1 cell line) | [82] | |||
miR-146a | Upregulated | Complement factor H | Evasion of HSV-1 from the innate immune response | Human neuronal-glial cells | [83] | ||
miR-373 | Upregulated | IRF1 | Inhibition of innate immune response | HeLa and patients with herpetic gingivostomatitis | [74] | ||
miR-155 | Deficiency | SOCS1 | Regulation of T cell differentiation | In vivo mouse model of herpes simplex encephalitis | [84] | ||
Upregulated | Unknown | - | In vivo acute viral encephalitis model—mouse brain | [85] | TARGET NOT KNOWN | ||
miR-183/96/182 | Upregulated | Unknown | - | Primary fibroblasts and neurons | [86] | ||
miR-15b, miR-26a, miR-141, miR-183/96/182, miR-200a, b, c, miR-429 1 | Upregulated | Unknown | - | In vivo acute viral encephalitis model—mouse brain | [85] |
1 All of these miRNAs are shown to be upregulated during HSV-1 infection, and syndecan-2 (Sdc2) has been shown to be a possible cellular target regulated by miR-96, miR-141, miR-183, and miR-200c.